DOI: http://dx.doi.org/10.18203/2349-3933.ijam20160206

A rare case report and literature overview: autoimmune polyglandular syndrome type II

Hasan Ergenc, Dilek Karakaya Arpaci, Ceyhun Varım, Aysel Gurkan Tocoglu, Ali Tamer

Abstract


Autoimmune diseases are a heterogeneous group of diseases with chronic humoral immune response against different tissue formation. Autoimmune polyglandular syndrome (APS) is also characterized by multiple organ autoimmune dysfunction. 43-year-old male patient was admitted with complaints of anorexia, malaise, rapid darkening on skin under the sun. The patient, stating in his medical background that levothyroxine TB with the diagnosis of hypothyroidism was started three years ago, had hypotension and hyperpigmentation. Hyponatremia, hyperkalemia, autoimmune hypothyroidism, primary adrenal insufficiency and atrophic gastritis was detected in examinations, significant improvements were observed in the general condition of the patient on whom glucocorticoids, and then levothyroxine TB replacement treatments were applied, and in blood pressure and laboratory parameters. Therefore, other organ autoimmunity should be sought in patients admitted with any autoimmune disease and be considered in follow-ups. We aimed to review the literature about APS and remind APS by this case.


Keywords


Autoimmune polyglandular syndrome, Chronic autoimmune thyroiditis, Adrenal insufficiency

Full Text:

PDF

References


Saygılı F. Autoimmune endocrine diseases. Turkiye Klinikleri J Endocrin Special Topics, 2010;3:1-5.

Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol. 2004;137:225-33.

Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed Ateneo Parmense. 2003;74:9-33.

Dilek E, İşcan B, Ekuklu G, Tütüncüler F. Retrospective evaluation of the cases diagnosed as Hashimoto’s Thyroiditis. Çocuk Dergisi. 2000;11:73-7.

Gibson Ds, Banha J, Penque D, Costa L, Conrads TP, Cahill DJ, et al, Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. J Proteomics. 2010;18:1045-60.

Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab. 2003;88:2983-92.

Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore). 1981;60:355-62.

Ward L, Paquette J, Seidman E. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J ClinEndocrinolMetab. 1999;84:844-52.

Yönem A. Poliglandüler endokrin yetmezlikler. In: Özata M, Yönem A, eds. Endokrinoloji Metabolizma ve Diyabet. baskı. İstanbul: İstanbul medikal yayıncılık. 2006:579-82.

Jaume JC. Endocrine autoimmunity. In: Greenspan FS, Gardner DG, eds. Basic and Clinical Endocrinology. 7th ed. USA: McGraw-HillCompanies. 2004:85-105.